Pathway | Total number of studies | Studies with positive genotype association or mutations implicated | Mean cohort size (range) | Genes independently verified [references] |
---|---|---|---|---|
Central nervous system | 20 | 13 | 85 (20 to 172) | |
Cardiac channelopathies | 16 | 13 | 141 (6 to 292) | |
Immune dysfunction | 20 | 10 | 103 (16 to 250) | |
Metabolism/energy | 23 | 5 | 178 (2 to 1304) | |
Nicotine response | 2 | 1 | 106, 159 | None |